» Articles » PMID: 25609736

Diabetic Nephropathy is Associated with Increased Urine Excretion of Proteases Plasmin, Prostasin and Urokinase and Activation of Amiloride-sensitive Current in Collecting Duct Cells

Overview
Date 2015 Jan 23
PMID 25609736
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic nephropathy (DN) is associated with hypertension, expanded extracellular volume and impaired renal Na(+) excretion. It was hypothesized that aberrant glomerular filtration of serine proteases in DN causes proteolytic activation of the epithelial sodium channel (ENaC) in the kidney by excision of an inhibitory peptide tract from the γ subunit.

Methods: In a cross-sectional design, urine, plasma and clinical data were collected from type 1 diabetic patients with DN (n = 19) and matched normoalbuminuric type 1 diabetics (controls, n = 20). Urine was examined for proteases by western immunoblotting, patch clamp and ELISA. Urine exosomes were isolated to elucidate potential cleavage of γENaC by a monoclonal antibody directed against the 'inhibitory' peptide tract.

Results: Compared with control, DN patients displayed significantly higher blood pressure and urinary excretion of plasmin(ogen), prostasin and urokinase that correlated directly with urine albumin. Western blotting confirmed plasmin, prostasin and urokinase in urine from the DN group predominantly. Urine from DN evoked a significantly larger amiloride-sensitive inward current in single collecting duct cells compared with controls. Immunoblotting of urine exosomes showed aquaporin 2 in all patient samples. Exosomes displayed a virtual absence of intact γENaC while moieties compatible with cleavage by furin only, were shown in both groups. Proteolytic cleavage by the extracellular serine proteases plasmin or prostasin was observed in DN samples predominantly.

Conclusion: DN is associated with increased urinary excretion of plasmin, prostasin and urokinase and proteolytic activation of ENaC that might contribute to impaired renal Na(+) excretion and hypertension.

Citing Articles

Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.

Isaksson G, Hinrichs G, Andersen H, Bach M, Weyer K, Zachar R J Am Soc Nephrol. 2024; 35(4):410-425.

PMID: 38254266 PMC: 11000727. DOI: 10.1681/ASN.0000000000000312.


Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome.

Fratila G, Sorohan B, Achim C, Andronesi A, Obrisca B, Lupusoru G J Clin Med. 2023; 12(21).

PMID: 37959360 PMC: 10648037. DOI: 10.3390/jcm12216895.


A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats.

Iwata Y, Deng Q, Kakizoe Y, Nakagawa T, Miyasato Y, Nakagawa M Int J Mol Sci. 2023; 24(21).

PMID: 37958726 PMC: 10650472. DOI: 10.3390/ijms242115743.


Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy.

Bohovyk R, Khedr S, Levchenko V, Stefanenko M, Semenikhina M, Kravtsova O Diabetes. 2023; 72(12):1795-1808.

PMID: 37722138 PMC: 10658073. DOI: 10.2337/db23-0032.


Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system.

Chatterjee E, Rodosthenous R, Kujala V, Gokulnath P, Spanos M, Lehmann H JCI Insight. 2023; 8(22).

PMID: 37707956 PMC: 10721327. DOI: 10.1172/jci.insight.165172.